N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine（CAS番号：2030-63-9）

N,5-ビス(4-クロロフェニル)-3-[(プロパン-2-イル)イミノ]-3,5-ジヒドロフェナジン-2-アミン

基本情報

N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine

CAS番号

2030-63-9

分子式

C27H22Cl2N4

分子量

473.41 g/mol

Quick Actions

基本的な物理特性

融点

210-213°C

沸点

616.26°C (rough estimate)

引火点

296.7°C

屈折率

1.6300 (estimate)

SMILES

CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl

InChI

InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3

InChIKey

WDQPAMHFFCXSNU-UHFFFAOYSA-N

LogP

7.489800000000005

pKa

8.37; also reported as 8.51(at 25℃)

トポロジカル極性表面積

42.21 Ų

水素結合ドナー/アクセプター

1 / 4

複雑度

829

分類と用途

安全情報

安全情報を表示

危険性の表示

H315; H319; H335

毒性

LD50 orally in mice, rats, and guinea pigs: >4 g/kg (Stenger)

同義語と参考文献

英語

  • Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-
  • B663
  • SR-05000001807-1
  • 2-Phenazinamine,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
  • N,5-Bis(4-chlorophenyl)-3-([1-methylethyl]imino)-3,5-dihydro-2-phenazinamine #
  • N,5-bis(4-chlorophenyl)-3-propan-2-ylimino-phenazin-2-amine
  • DTXSID7022839
  • GTPL9184
  • SCHEMBL26757
  • 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
  • HY-B1046
  • C2866
  • NCGC00016600-02
  • CLOFAZIMINE [ORANGE BOOK]
  • B 663 (VAN)
  • HMS3370N05
  • AMY22515
  • HMS3713K13
  • Lamprene (TN)
  • CLOFAZIMINE [USAN]
  • J-013203
  • G-30320
  • AKOS026749881
  • BRD-K56614220-001-10-9
  • B. 663
  • NC00409
  • Pharmakon1600-01505974
  • SMR000058704
  • Phenazine, 2,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-
  • Chlofazimine
  • C06915
  • cid_2794
  • (3E)-N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine
  • DB00845
  • 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]
  • NS00011720
  • N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine
  • 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin
  • 2030-63-9
  • CLOFAZIMINE [VANDF]
  • CHEMBL1083384
  • CLOFAZIMINE [USP-RS]
  • Tox21_110516
  • HMS3652A16
  • HMS2052B05
  • (3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine
  • Prestwick0_000376
  • SCHEMBL26758
  • Clofazimine, European Pharmacopoeia (EP) Reference Standard
  • 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-
  • NSC-141046
  • MLS006010789
  • B 663, pharmaceutical
  • Clofazimine for system suitability, European Pharmacopoeia (EP) Reference Standard
  • HMS2096K13
  • CLOFAZIMINE [EP MONOGRAPH]
  • HMS3394B05
  • EINECS 217-980-2
  • KS-1412
  • CLOFAZIMINE [INN]
  • MLS000028617
  • MMV687800
  • NCGC00016600-07
  • NCGC00016600-09
  • SR-05000001807-2
  • MLS001424318
  • Clofazimine [USAN:USP:INN:BAN]
  • SR-01000000259-6
  • N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine
  • 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine
  • CLOFAZIMINE [USP IMPURITY]
  • 2-Phenazinamine,5-dihydro-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-
  • Prestwick2_000376
  • CCG-269477
  • BCP07792
  • CLOFAZIMINE [JAN]
  • NSC-759283
  • SMR004701474
  • Clofazimine 100 microg/mL in Acetonitrile
  • Phenazine,10-dihydro-2-(isopropylimino)-
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine
  • 2458811-14-6
  • B-663
  • N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine
  • BIDD:PXR0147
  • Phenazine,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-
  • Clofaziminum
  • (4-Chloro-phenyl)-[5-(4-chloro-phenyl)-3-isopropylimino-3,5-dihydro-phenazin-2-yl]-amine
  • Prestwick3_000376
  • 2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-
  • 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
  • NCGC00179529-01
  • D959AE5USF
  • Clofazimina
  • CPD000058704
  • UNII-D959AE5USF
  • SPBio_002452
  • BSPBio_000531
  • N,5-bis(4-chlorophenyl)-3-propan-2-ylimino-2-phenazinamine
  • NCGC00016600-08
  • Q418611
  • G 30320
  • KUC109573N
  • SR-05000001807
  • HMS2093J10
  • KSC-27-052A
  • 2-Phenazinamine,N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
  • COLFAZIMINE [VANDF]
  • FT-0657414
  • NCGC00016600-04
  • D00278
  • BDBM50378783
  • NSC759283
  • Clofazimina [INN-Spanish]
  • (3E)-N,5-bis(4-chlorophenyl)-3-isopropylimino-phenazin-2-amine
  • s4107
  • (E)-N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine
  • B 663
  • Prestwick_685
  • EN300-267815
  • AKOS015896438
  • Lamprene
  • SW196840-4
  • CLOFAZIMINE [WHO-IP]
  • BPBio1_000585
  • BDBM50318909
  • 4-25-00-03033 (Beilstein Handbook Reference)
  • EN300-21680301
  • SR-01000000259
  • CAS-2030-63-9
  • CLOFAZIMINE [MI]
  • Clofazimine, United States Pharmacopeia (USP) Reference Standard
  • SBI-0206865.P001
  • Lampren
  • Riminophenazine
  • HMS1569K13
  • CLOFAZIMINE [WHO-DD]
  • WDQPAMHFFCXSNU-KRUMMXJUSA-N
  • SMP2_000339
  • N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine
  • Prestwick1_000376
  • CCG-101159
  • NSC 141046
  • CLOFAZIMINUM [WHO-IP LATIN]
  • Clofaziminum [INN-Latin]
  • Clofazimine (JAN/USP/INN)
  • 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
  • CS-4567
  • CLOFAZIMINE [USP MONOGRAPH]
  • DTXCID302839
  • A814428
  • clofazimine
  • HMS2231B04
  • Z2037279473
  • 2-p-Chloranilino-5-p-chlorphenyl-3,5-dihydro-3-isopropylimino-phenazin
  • Colfazimine
  • SCHEMBL5663361
  • NSC141046
  • B 663 (Pharmaceutical)
  • NCGC00016600-03
  • NCGC00016600-01
  • MFCD00056793
  • BRN 0060420
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine
  • CHEMBL1292
  • CHEBI:3749
  • CLOFAZIMINE [MART.]
  • NCGC00016600-05
  • Clofazimine
  • Clofazimine-d7
  • 2-(4-Chlor-anilino)-5-(4-chlor-phenyl)-3-isopropylamino-phenazinium-betain
  • 2-(4-chloro-anilino)-5-(4-chloro-phenyl)-3-isopropylamino-phenazinium-betaine
  • Clo
  • Clofazimine (N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine

MDL_Number

MFCD00056793

CAS番号

2030-63-9

Customs_Code

35040000

Merck_Index

2373

サプライヤー情報

サプライヤー名 会員レベル 認証状況 主要カテゴリー 最小注文数量 アクション
中国中国 - Beijing Solabe Technology Co., Ltd.
中国中国 - Shanghai Huicheng Biotechnology Co., Ltd.
中国中国 - Shanghai Bohui Meike Chemical Technology Co., Ltd.
中国中国 - Changzhou Kewei Fine Chemical Co., Ltd.
中国中国 - Zaozhuang Hanbang Chemical Industry Co., Ltd.
中国中国 - Nanjing Yanqiao Technology Co., Ltd.
ドイツドイツ - Addivant Germany GmbH
ドイツドイツ - Eurofins GfA Gesellschaft für Arbeitsplatz und Umweltanalytik mbH

関連化合物

42330-95-0 - 4-Chloro-1-butanamine

42330-95-0

1915-42-0 - N-(4-Pyridinyl)-4-pyridinamine

1915-42-0

57423-71-9 - (1R,2R,4R,6S,11R,12S,15R,18S,19R,20S,21S,23R,26R)-15-Hydroxy-11,18,21-trimethyl-5,17,24,28,29-pentaoxanonacyclo[17.9.1.1~1,20~.0~2,12~.0~4,6~.0~6,11~.0~15,19~.0~18,23~.0~21,26~]triacont-8-ene-10,16,25 ,30-tetrone

57423-71-9

7770-78-7 - (3R,4R)-4-(3,4-Dimethoxybenzyl)-3-(4-hydroxy-3-methoxybenzyl)dihydro-2(3H)-furanone

7770-78-7

114306-00-2 - 5-Chloro-1H-indol-3-yl acetate

114306-00-2

133550-34-2 - AG 555

133550-34-2

53052-03-2 - 3-(Cyclohexylamino)-1,2-propanediol

53052-03-2

41330-23-8 - cyclopentane-1,2-diamine

41330-23-8

おすすめジャーナル

Chemical Reviews

Chemical Reviews

Advances in Colloid and Interface Science

Advances in Colloid and Interface Science

Canadian Metallurgical Quarterly

Canadian Metallurgical Quarterly

Ferroelectrics

Ferroelectrics

Biopolymers

Biopolymers

Corrosion Science

Corrosion Science

Chemistry of Natural Compounds

Chemistry of Natural Compounds

Anti-Corrosion Methods and Materials

Anti-Corrosion Methods and Materials

Cement and Concrete Research

Cement and Concrete Research

Doklady Chemistry

Doklady Chemistry

関連論文

Ether-functionalization of monoethanolamine (MEA) for reversible CO2 capture under solvent-free conditions with high-capacity and low-viscosity

An-Hua Liu, Jie-Jie Li, Bai-Hao Ren, Xin-Ru Sha, He Jiang, Xiao-Bing Lu

2019-12-04 Paper

DOI: 10.1039/C9SE00756C

Chemoproteomics-based target profiling of sinomenine reveals multiple protein regulators of inflammation

Lianguo Chen, Hong-jian Wang, Teng-fei Ji, Chong-Jing Zhang

2021-05-06 Communication

DOI: 10.1039/D1CC01522B

Contents list

2021-06-04 Front/Back Matter

DOI: 10.1039/D1BM90055B

Retraction: Chemical synthesis and antigenic activity of a phosphatidylinositol mannoside epitope from Mycobacterium tuberculosis

Shi-Yuan Zhao, Na Li, Wan-Yue Luo, Nan-Nan Zhang, Rong-Ye Zhou, Chen-Yu Li

2021-06-06 Retraction

DOI: 10.1039/D1CC90195H

Life cycle assessment of plasma-assisted ethylene production from rich-in-methane gas streams

Evangelos Delikonstantis, Elorri Igos, Michael Augustinus, Enrico Benetto

2020-01-08 Paper

DOI: 10.1039/C9SE00736A

Life cycle assessment of power-to-gas with biogas as the carbon source

Xiaojin Zhang, Julia Witte, Tilman Schildhauer, Christian Bauer

2019-12-17 Paper

DOI: 10.1039/C9SE00986H

Catalogue of self-targeting nano-medical inventions to accelerate clinical trials

Samar A. Alsudir

2021-04-15 Review Article

DOI: 10.1039/D1BM00235J

Biomaterials Science Emerging Investigators 2021

Maria E. Southall

2021-06-02 Editorial

DOI: 10.1039/D1BM90053F

A model-based comparison of Ru and Ni catalysts for the Sabatier reaction

2019-12-26 Paper

DOI: 10.1039/C9SE00787C

Tessellation strategy for the interfacial synthesis of an anthracene-based 2D polymer via [4+4]-photocycloaddition

Renzeng Chen, Danbo Wang, Wenbo Hao, Feng Shao, Yingjie Zhao

2021-05-07 Communication

DOI: 10.1039/D1CC02179F

このウェブサイトは、基本機能を確保し、ユーザー体験を向上させるためにCookieを使用しています。使用するCookie：

  • 必須Cookie：サイトの基本機能（認証、セキュリティ）に必要です。無効にすることはできません。
  • 分析Cookie：サイトの使用状況を理解し、サービスを改善するのに役立ちます。

プライバシー設定でいつでも設定を変更できます。詳細は Privacy Policy for more details.